Quality of life after laparoscopic removal of Essure ® sterilization devices

• Published in: European Journal of Obstetrics & Gynecology and Reproductive Biology 2019-07, Vol.3, p.100054, Article 100054
• Main Authors: Chene, Gautier, Cerruto, Emanuele, Moret, Stephanie, Lebail-Carval, Karine, Chabert, Philippe, Mellier, Georges, Nohuz, Erdogan, Lamblin, Gery, Clark, T Justin
• Format: Article
• Language: English
• Subjects: Gynaecology; Life Sciences
• ISSN: 2590-1613; 0301-2115; 2590-1613
• DOI: 10.1016/j.eurox.2019.100054

To assess changes in quality of life after laparoscopic removal of Essure sterilization devices (Bayer AG, Leverkusen, Germany). In this prospective observational study in an academic research hospital, 80 women with new or worsening symptoms since placement of Essure sterilization devices undergoing subsequent surgical removal were included. Laparoscopic removal of Essure devices and salpingectomy with or without cornual excision were performed. Concomitant uterine procedures could be associated where indicated for gynaecological complaints. Comparison using the T student test for coupled series was done in this before-and-after study. Health related quality of life (HRQL) was the primary outcome measured by the Short Form 12 (SF-12) questionnaire and a global 10 cm visual analogue scale (VAS). Secondary outcomes included assessment of pain, using continuous (VAS) and ordinal scales (Modified McGill Pain Questionnaire), menstrual bleeding (pictorial blood loss assessment chart (PBAC) score) and surgical feasibility and safety. There was a significant improvement in quality of life in both mental and physical health aspects of the SF-12 (34.02 (+/-1.19) vs. 49.61 (+/-1.42, P